The results of a clinical trial of extended-release buprenorphine injections (BUP-XR), an opioid agonist treatment (OAT), demonstrate high retention and treatment satisfaction.
Forecasts estimate that by 2030 about one in three people living in western nations will be aged 65 years or older.
We are delighted to announce NCETA’s new Director, Professor Jacqueline Bowden. Jacquie has a background in both psychology (BA Arts, Hons and PhD) and public health (Master of Public Health).
